Skip to main content
UniHealth

Doctor search

Joshua J Mooney, MD

Pulmonary Disease · Stanford

NPI 1821225541

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
17
3 carriers
Offices
4

Offices

4 locations · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.

Plans that list them

17 plans · 3 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Mooney’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

17 of 17 plans

Plans whose provider directory lists this clinician
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Silicon (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health smartHMO (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health the ONE (HMO)Alignment Health PlanListedOct 3, 2026
SCAN Balance (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
SCAN Classic (HMO)SCAN Health PlanListedOct 3, 2026
SCAN MyChoice (HMO)SCAN Health PlanListedOct 3, 2026
SCAN Strive (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
DualConnect (HMO D-SNP)Santa Clara Family Health PlanListedSep 1, 2026

California Medical Board record

Licence A113812 · Current

Licensed to practise in California · since 2010 · expires 2028-08-31 · University of Minnesota Medical School.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
  • Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend it
    Overall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%
See every measure and the patient survey for Stanford Health Care Tri-Valley

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care Tri-Valley
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.178BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.237BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.79 (0 to 1.73) · 1,041 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.79 (0.5 to 1.08)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths145.81 (96.5 to 195.12) · 72 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.9 · 55 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths8.6 · 92 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12.5 · 96 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9.5 · 395 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 391 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.1 · 162 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3 · 1,736 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.16 (0 to 0.37) · 4,425 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.22 (0.02 to 0.41) · 4,771 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.45 (1.46 to 5.44) · 1,403 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.5 (0.05 to 2.94) · 645 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths1.81 (0.38 to 3.24) · 1,279 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths8.53 (3.2 to 13.85) · 639 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.15 (1.89 to 8.41) · 648 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.61 (0.14 to 3.07) · 370 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.16 (0 to 0.83) · 4,160 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4 · 74 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.369No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections1.112No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits13.1 · 110 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.1 · 437 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-5.8 · 94 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-19.3 · 456 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-0.3 · 402 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits15.8 · 358 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits6.8 (4.7 to 9.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits10.1 (7.5 to 13.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.3 · 80 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.9 · 46 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.3 · 92 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.4 (9.6 to 16.2) · 1,532 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1 (0.8 to 1.2) · 929 casesNo differentJan 2024 – Dec 2024

What patients said (1,268 patients answered, 26% of those asked)

Patient survey stars by topic at Stanford Health Care Tri-Valley
Cleanliness3
Nurse communication3
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating3
Quietness2
Recommend hospital4
Share of patients giving the best answer at Stanford Health Care Tri-Valley
Room was "always" clean65%
Nurses "always" communicated well77%
Doctors "always" communicated well79%
Staff "always" explained58%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge88%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully78%
Doctors "always" treated them with courtesy and respect86%
Patients who gave a rating of "9" or "10" (high)70%
Staff "always" explained new medications72%
Nurses "always" explained things so they could understand73%
Nurses "always" listened carefully74%
Nurses "always" treated them with courtesy and respect84%
"Always" quiet at night42%
"YES", patients would definitely recommend the hospital74%
Staff "always" explained possible side effects44%
Yes, staff "did" give patients information about possible symptoms89%

Original Medicare doctor bills

$172,916

Medicare paid this office $172,916 for 934 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes72$58,937$105
Long return visit (40+ min)101$21,140$127
Critical care, first 30-74 minutes21$16,665$185
Test to measure expiratory airflow and volume607$12,277$7
Return visit (30+ min)94$10,615$84
See all 17 services
Every Original Medicare service billed
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes72$58,937$105
Long return visit (40+ min)101$21,140$127
Critical care, first 30-74 minutes21$16,665$185
Test to measure expiratory airflow and volume607$12,277$7
Return visit (30+ min)94$10,615$84
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes42$9,376$70
Return visit (30+ min)55$7,608$110
Test for exercise-induced lung stress314$7,014$19
Test to examine how well the lungs exchange gases516$5,989$8
Hospital discharge day management, more than 30 minutes32$3,908$103
New patient visit (60+ min)21$3,425$163
Long return visit (40+ min)18$2,774$154
Irrigation and suction of lung airways to obtain cells using an endoscope18$2,754$86
New patient visit (60+ min)13$2,497$192
Test to determine lung volumes using sensors88$941$10
Test to measure expiratory airflow and volume changes before and after medication administration99$905$9
Test for exercise-induced lung stress18$363$17

Who their Medicare patients are

934 Original Medicare patients in 2024. Average age 72 · Under 65 16% · 85 and older 9% · Women 54% · Also on Medicaid 26% · Health risk score 2.47. Above the middle of the specialty; the typical pulmonary disease clinician is at 2.13.

Conditions among them: High blood pressure 75% · Coronary heart disease 40% · COPD 39% · Diabetes 37% · Chronic kidney disease 36% · Heart failure 29% · Atrial fibrillation 26% · Depression 21% · Cancer 17% · Stroke 7% · Dementia 6%.

The office billed $921,039, Medicare allowed $219,619 and paid $172,916; for 4,384 services of 26 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
20249344,384722.47$921,039$172,916
20238494,089712.28$706,555$150,176
20227313,893712.15$672,272$148,895
20217213,582712.19$569,089$128,508
20206963,301702.37$629,349$121,534
20196712,897692.53$467,379$102,094
20185272,873682.56$505,841$105,519
20175252,242682.32$535,433$102,576
20163601,324672.39$320,089$63,139
201574161642.82$61,283$13,980

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 17 services

Original Medicare services billed in 2023
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes60$48,352$108
Long return visit (40+ min)116$25,780$131
Return visit (30+ min)96$13,858$90
Critical care, first 30-74 minutes13$12,503$192
Test to measure expiratory airflow and volume556$11,507$7
Test for exercise-induced lung stress397$9,606$19
Test to examine how well the lungs exchange gases489$5,582$8
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes23$4,159$70
Hospital discharge day management, more than 30 minutes23$2,918$108
New patient visit (60+ min)15$2,505$167
Long return visit (40+ min)15$2,380$119
Initial hospital care with moderate level of medical decision making at least 75 minutes11$1,919$160
Return visit (30+ min)15$1,460$91
Irrigation and suction of lung airways to obtain cells using an endoscope12$1,342$79
Test to determine lung volumes using sensors102$1,106$11
Test to measure expiratory airflow and volume changes before and after medication administration105$974$9
Test for exercise-induced lung stress14$300$20

2022: 14 services

Original Medicare services billed in 2022
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes57$52,227$94
Long return visit (40+ min)90$20,219$128
Return visit (30+ min)117$16,875$87
Test for exercise-induced lung stress377$9,419$19
Test to measure expiratory airflow and volume506$9,328$7
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes24$8,107$65
Critical care, first 30-74 minutes12$7,681$197
Test to examine how well the lungs exchange gases456$5,209$8
Initial hospital care with moderate level of medical decision making at least 75 minutes16$3,625$181
Hospital discharge day management, more than 30 minutes27$3,178$96
New patient visit (60+ min)15$2,268$151
Irrigation and suction of lung airways to obtain cells using an endoscope12$2,156$98
Test to determine lung volumes using sensors101$1,084$11
Test to measure expiratory airflow and volume changes before and after medication administration105$978$9

2021: 14 services

Original Medicare services billed in 2021
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes45$40,571$95
Return visit (30+ min)115$18,501$100
Long return visit (40+ min)77$13,386$122
Test for exercise-induced lung stress447$12,558$19
Test to measure expiratory airflow and volume492$9,382$7
Test to examine how well the lungs exchange gases392$4,957$8
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes12$3,784$66
New patient visit (60+ min)17$3,284$193
Initial hospital care with moderate level of medical decision making at least 75 minutes14$2,931$183
Hospital discharge day management, more than 30 minutes20$2,301$100
Return visit (30+ min)11$1,358$91
Test to measure expiratory airflow and volume changes before and after medication administration38$376$9
Test to determine lung volumes using sensors33$361$11
Telehealth originating site facility fee12$357$24

2020: 16 services

Original Medicare services billed in 2020
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes44$36,592$97
Return visit (30+ min)135$15,969$72
Long return visit (40+ min)81$10,771$90
Test for exercise-induced lung stress334$9,053$20
Test to measure expiratory airflow and volume474$8,044$8
Test to examine how well the lungs exchange gases400$4,356$8
Irrigation and suction of lung airways to obtain cells using an endoscope29$4,227$80
Initial hospital care with moderate level of medical decision making at least 75 minutes15$3,144$185
Hospital discharge day management, more than 30 minutes22$2,877$103
Return visit (30+ min)23$2,610$82
Biopsy of lobe of lung using an endoscope, 1 lobe12$2,133$152
New patient visit (45+ min)11$1,240$113
Test to measure expiratory airflow and volume changes before and after medication administration90$974$10
Telehealth originating site facility fee21$740$22
Test to determine lung volumes using sensors70$724$10
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes21$261$11

2019: 15 services

Original Medicare services billed in 2019
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes44$28,417$93
Return visit (30+ min)149$16,718$70
Long return visit (40+ min)79$11,412$93
Test for exercise-induced lung stress348$9,896$20
Test to measure expiratory airflow and volume429$5,991$8
Test to examine how well the lungs exchange gases367$4,023$8
New patient visit (45+ min)36$3,890$108
Biopsy of lobe of lung using an endoscope, 1 lobe18$3,544$161
Irrigation and suction of lung airways to obtain cells using an endoscope28$3,090$66
Hospital discharge day management, more than 30 minutes22$2,677$99
Test to measure expiratory airflow and volume changes before and after medication administration122$1,500$12
Return visit (30+ min)12$1,233$77
Test to determine lung volumes using sensors86$982$11
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes16$200$11
Test to determine lung volumes using gas dilution or washout16$181$11

2018: 17 services

Original Medicare services billed in 2018
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes42$27,524$94
Return visit (30+ min)131$15,086$68
Long return visit (40+ min)90$13,215$98
Test for exercise-induced lung stress266$7,348$20
Test to measure expiratory airflow and volume373$7,229$7
Irrigation and suction of lung airways to obtain cells using an endoscope41$4,661$80
Test to examine how well the lungs exchange gases296$3,829$8
Initial hospital care with moderate level of medical decision making at least 75 minutes17$3,456$182
Biopsy of lobe of lung using an endoscope, 1 lobe17$3,189$159
Hospital discharge day management, more than 30 minutes18$2,173$99
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes12$1,896$65
Return visit (30+ min)14$1,626$74
New patient visit (45+ min)16$1,614$101
Test to measure expiratory airflow and volume changes before and after medication administration55$661$12
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes30$441$11
Test to determine lung volumes using sensors37$411$11
Test to determine lung volumes using gas dilution or washout15$167$11

2017: 19 services

Original Medicare services billed in 2017
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes53$32,338$93
Return visit (30+ min)135$14,709$66
Long return visit (40+ min)62$9,025$93
Test to measure expiratory airflow and volume314$4,281$7
Irrigation and suction of lung airways to obtain cells using an endoscope41$4,187$72
Pulmonary exercise testing119$4,054$26
Biopsy of lobe of lung using an endoscope, 1 lobe22$3,988$160
New patient visit (45+ min)26$2,942$113
Initial hospital care with moderate level of medical decision making at least 75 minutes13$2,901$181
Test to examine how well the lungs exchange gases268$2,840$8
Return visit (30+ min)24$2,670$76
New patient visit (45+ min)17$2,272$134
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes13$2,073$65
Hospital discharge day management, more than 30 minutes18$2,062$98
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes11$1,342$122
Test to measure expiratory airflow and volume changes before and after medication administration66$766$12
Test to determine lung volumes using sensors50$544$11
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes31$415$11
Test to measure expiratory airflow and volume13$99$8

2016: 15 services

Original Medicare services billed in 2016
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes33$15,925$93
Return visit (30+ min)116$11,722$66
Long return visit (40+ min)32$3,666$99
New patient visit (45+ min)32$3,576$112
Biopsy of lobe of lung using an endoscope, 1 lobe16$3,555$169
Test to measure expiratory airflow and volume222$2,960$8
Pulmonary exercise testing75$2,603$27
Hospital discharge day management, more than 30 minutes19$2,355$94
Initial hospital care with moderate level of medical decision making at least 75 minutes11$1,983$180
New patient visit (45+ min)14$1,873$134
Irrigation and suction of lung airways to obtain cells using an endoscope22$1,700$52
Test to examine how well the lungs exchange gases152$1,505$8
Return visit (30+ min)11$908$83
Test to measure expiratory airflow and volume changes before and after medication administration19$212$11
Test to determine lung volumes using sensors15$155$10

2015: 3 services

Original Medicare services billed in 2015
Return visit (30+ min)46$3,796$70
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes14$3,359$93
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes14$1,493$65

Medicaid work

$20,884 in 2024

Medicaid paid $20,884 for 1,479 billed services this clinician did in 2024, up to 75 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES194$6,178
Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation771$5,450
PULMONARY STRESS TESTING211$3,740
Long return visit (40+ min)71$3,718
Diffusing capacity232$1,797
Medicaid work by year
20241,479575$20,884
20231,667575$17,105
20221,494568$20,272
20211,296550$14,051
2020773557$6,372
2019410432$3,696
2018411335$3,299
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation974$6,211
Long return visit (40+ min)107$4,316
PULMONARY STRESS TESTING242$3,602
SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES74$1,729
Diffusing capacity270$1,247

2022

Largest Medicaid services in 2022
SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES170$5,927
Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation785$5,122
PULMONARY STRESS TESTING245$4,502
Long return visit (40+ min)59$3,304
Diffusing capacity235$1,417

2021

Largest Medicaid services in 2021
PULMONARY STRESS TESTING279$4,823
Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation649$4,053
SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES114$3,142
Diffusing capacity228$1,147
Long return visit (40+ min)26$887

2020

Largest Medicaid services in 2020
Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation411$2,649
PULMONARY STRESS TESTING163$2,573
Diffusing capacity169$828
EVALUATION OF WHEEZING16$204
Plethysmography for determination of lung volumes and, when performed, airway resistance14$118

2019

Largest Medicaid services in 2019
PULMONARY STRESS TESTING140$2,127
Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation194$1,163
Diffusing capacity63$352
EVALUATION OF WHEEZING13$53

2018

Largest Medicaid services in 2018
Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation328$2,237
PULMONARY STRESS TESTING59$922
Diffusing capacity24$140

Drugs they prescribed that Part D paid

$3,138,684

Pharmacies billed $3,138,684 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

2,328 generic and 353 brand-name prescriptions · $3,138,684 in drug cost · 398 antibiotic prescriptions to 98 people.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Ofev212$2,646,472$12,483
Prevymis12$98,374$8,198
Posaconazole103$65,022$631
Pirfenidone48$31,192$650
Atovaquone35$20,203$577
See all 44 drugs
Every Part D drug this clinician prescribed
Ofev212$2,646,472$12,483
Prevymis12$98,374$8,198
Posaconazole103$65,022$631
Pirfenidone48$31,192$650
Atovaquone35$20,203$577
Valganciclovir101$17,458$173
Breo Ellipta38$16,802$442
Everolimus34$14,747$434
Mycophenolate Mofetil99$14,738$149
Itraconazole44$11,729$267
Eliquis15$10,479$699
Tacrolimus115$6,265$54
Azathioprine18$2,207$123
Sulfamethoxazole-Trimethoprim234$1,438$6
Pantoprazole194$1,427$7
Acyclovir158$1,408$9
Azithromycin114$1,186$10
Prednisone147$1,038$7
Clotrimazole19$1,004$53
Albuterol Sulfate Hfa25$924$37
Rosuvastatin130$766$6
Hydralazine15$417$28
Warfarin36$369$10
Ondansetron Odt19$364$19
Gabapentin17$254$15
Mirtazapine25$233$9
Omeprazole34$224$7
Amlodipine Besylate70$217$3
Metoprolol52$177$3
Fluticasone Propionate12$170$14
Carvedilol33$167$5
Pravastatin37$128$3
Levothyroxine25$127$5
Escitalopram12$112$9
Metoclopramide18$103$6
Furosemide32$85$3
Hydroxyzine13$83$6
Tamsulosin14$65$5
Metoprolol17$64$4
Alcohol Prep Pads16$62$4
Glipizide12$58$5
Alendronate33$55$2
Trazodone20$41$2
Amoxicillin29$31$1

Year by year

Part D prescribing by year
20242,702246None13%$3,138,684
20232,075232NoneNone$2,880,375
20221,5461900% (0)20%$2,815,352
20212,139204NoneNone$3,495,422
20203,064216None17%$3,635,987
20192,607211NoneNone$3,034,156
20181,4221590% (0)24%$2,229,033
2017420910% (0)None$1,269,997
2016186610% (0)30%$293,619
201574240% (0)27%$34,339
201433None0% (0)88%$15,806
201328None0% (0)None$2,444

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 36 drugs

Part D drugs prescribed in 2023
Ofev195$2,391,347$12,263
Pirfenidone39$88,740$2,275
Posaconazole55$71,068$1,292
Atovaquone30$22,289$743
Itraconazole45$21,122$469
Valganciclovir81$20,374$252
Everolimus43$19,232$447
Symbicort28$17,992$643
Mycophenolate Mofetil106$13,021$123
Advair Diskus19$10,799$568
Tacrolimus89$7,338$82
Pantoprazole116$2,209$19
Acyclovir117$2,192$19
Azithromycin98$1,543$16
Sirolimus13$1,533$118
Sulfamethoxazole-Trimethoprim166$1,307$8
Prednisone125$1,035$8
Rosuvastatin46$833$18
Warfarin34$717$21
Ondansetron Odt15$688$46
Clotrimazole11$668$61
Albuterol Sulfate Hfa23$510$22
Gabapentin20$460$23
Azathioprine16$424$27
Amlodipine Besylate47$373$8
Alendronate32$357$11
Carvedilol21$353$17
Furosemide35$218$6
Pravastatin17$182$11
Omeprazole21$146$7
Metoprolol17$119$7
Mirtazapine13$110$8
Levothyroxine11$105$10
Levofloxacin13$93$7
Amoxicillin23$49$2
Folic Acid13$43$3

2022: 33 drugs

Part D drugs prescribed in 2022
Ofev176$2,163,541$12,293
Esbriet13$133,860$10,297
Pirfenidone29$108,533$3,743
Posaconazole35$108,387$3,097
Itraconazole53$25,939$489
Atovaquone24$25,156$1,048
Everolimus43$22,303$519
Symbicort22$17,003$773
Valganciclovir49$12,160$248
Mycophenolate Mofetil59$11,573$196
Mycophenolic Acid12$5,636$470
Tacrolimus30$3,974$132
Clotrimazole19$3,417$180
Enoxaparin11$2,341$213
Sirolimus12$1,972$164
Azithromycin72$1,924$27
Azathioprine21$1,743$83
Albuterol Sulfate Hfa25$1,627$65
Prednisone110$1,311$12
Pantoprazole88$1,236$14
Rosuvastatin31$981$32
Acyclovir84$958$11
Sulfamethoxazole-Trimethoprim84$432$5
Metoprolol44$376$9
Carvedilol19$302$16
Mirtazapine14$290$21
Pravastatin23$276$12
Ondansetron Odt28$199$7
Warfarin12$111$9
Alendronate16$72$5
Amlodipine Besylate34$71$2
Furosemide11$50$5
Levothyroxine14$49$4

2021: 35 drugs

Part D drugs prescribed in 2021
Ofev233$2,747,923$11,794
Esbriet34$326,653$9,607
Posaconazole22$66,383$3,017
Itraconazole90$29,014$322
Valganciclovir69$22,421$325
Symbicort24$14,885$620
Everolimus21$14,568$694
Clotrimazole89$9,820$110
Mycophenolate Mofetil87$9,771$112
Tacrolimus54$8,729$162
Azithromycin82$2,552$31
Sirolimus11$2,362$215
Omega-3 Acid Ethyl Esters12$2,105$175
Azathioprine23$2,021$88
Pantoprazole122$1,770$15
Prednisone154$1,585$10
Sulfamethoxazole-Trimethoprim178$1,164$7
Rosuvastatin32$941$29
Acyclovir85$917$11
Nystatin19$743$39
Pravastatin39$573$15
Hydralazine15$389$26
Gabapentin24$310$13
Fluticasone Propionate22$285$13
Famotidine16$259$16
Alendronate53$248$5
Ondansetron Odt14$217$16
Omeprazole23$188$8
Metoprolol55$179$3
Amlodipine Besylate59$176$3
Levothyroxine24$155$6
Furosemide20$126$6
Fludrocortisone Acetate13$118$9
Amoxicillin28$66$2
Glipizide11$38$3

2020: 40 drugs

Part D drugs prescribed in 2020
Ofev193$2,219,557$11,500
Esbriet60$622,051$10,368
Posaconazole40$175,208$4,380
Cresemba12$112,312$9,359
Itraconazole122$59,253$486
Valganciclovir122$48,161$395
Atovaquone25$26,256$1,050
Mycophenolate Mofetil153$18,897$124
Mycophenolic Acid12$16,076$1,340
Symbicort34$15,974$470
Tacrolimus124$13,230$107
Clotrimazole115$10,527$92
Spiriva14$9,297$664
Advair Diskus14$9,155$654
Pantoprazole211$2,458$12
Azithromycin123$2,150$17
Omega-3 Acid Ethyl Esters11$2,045$186
Azathioprine25$1,867$75
Sulfamethoxazole-Trimethoprim286$1,565$5
Prednisone212$1,428$7
Acyclovir140$1,425$10
Sirolimus13$1,271$98
Ultra-Fine Short Pen Needle17$1,029$61
Nystatin29$898$31
Pravastatin77$806$10
Omeprazole38$681$18
Rosuvastatin35$560$16
Fluticasone Propionate32$501$16
Alendronate78$476$6
Diltiazem13$446$34
Amlodipine Besylate92$350$4
Metoprolol70$341$5
Famotidine24$209$9
Mirtazapine15$177$12
Levothyroxine15$168$11
Furosemide27$137$5
Gabapentin28$125$4
Atorvastatin17$109$6
Amoxicillin20$41$2
Escitalopram13$26$2

2019: 45 drugs

Part D drugs prescribed in 2019
Ofev164$1,698,814$10,359
Esbriet79$733,336$9,283
Noxafil27$185,715$6,878
Posaconazole20$94,117$4,706
Itraconazole130$68,256$525
Valganciclovir109$53,477$491
Creon11$37,575$3,416
Zortress19$16,501$868
Mycophenolate Mofetil121$15,015$124
Atovaquone14$12,086$863
Symbicort27$11,616$430
Mycophenolic Acid13$10,130$779
Advair Diskus23$10,032$436
Clotrimazole116$8,444$73
Tacrolimus97$7,204$74
Pantoprazole175$2,485$14
Azathioprine31$2,279$74
Sulfamethoxazole-Trimethoprim246$1,451$6
Azithromycin88$1,448$16
Prednisone176$1,367$8
Pravastatin89$1,102$12
Acyclovir127$902$7
Nystatin12$492$41
Bupropion Hcl Sr11$440$40
Ondansetron18$421$23
Bethanechol Chloride12$383$32
Omeprazole12$349$29
Diltiazem 24hr Er (Cd)14$315$23
Ondansetron Odt18$314$17
Alendronate36$273$8
Fluticasone Propionate24$272$11
Amlodipine Besylate52$267$5
Famotidine31$234$8
Gabapentin28$222$8
Metoprolol43$194$5
Atorvastatin14$191$14
Levofloxacin14$129$9
Furosemide26$115$4
Loperamide11$101$9
Fluoxetine16$86$5
Amoxicillin23$78$3
Citalopram Hbr14$58$4
Losartan13$57$4
Glipizide11$49$4
Ranitidine12$24$2

2018: 30 drugs

Part D drugs prescribed in 2018
Ofev163$1,547,755$9,495
Esbriet39$361,553$9,271
Noxafil22$143,416$6,519
Valganciclovir29$23,389$807
Itraconazole48$22,062$460
Sporanox16$21,404$1,338
Mycophenolate Mofetil112$11,314$101
Advair Diskus13$5,678$437
Clotrimazole49$3,621$74
Tacrolimus33$2,194$66
Azathioprine13$1,822$140
Ventolin Hfa23$1,305$57
Pantoprazole74$778$11
Azithromycin43$743$17
Pravastatin56$713$13
Ultra-Fine Nano Pen Needle11$603$55
Sulfamethoxazole-Trimethoprim103$567$6
Prednisone73$562$8
Bethanechol Chloride11$470$43
Gabapentin27$462$17
Acyclovir57$323$6
Diltiazem 24hr Er (Cd)17$293$17
Ranitidine31$250$8
Warfarin18$171$9
Famotidine27$167$6
Alendronate15$96$6
Furosemide17$83$5
Citalopram Hbr18$81$5
Fluoxetine11$73$7
Amlodipine Besylate14$41$3

2017: 5 drugs

Part D drugs prescribed in 2017
Ofev102$930,567$9,123
Esbriet33$275,536$8,350
Mycophenolate Mofetil104$8,707$84
Prednisone49$485$10
Sulfamethoxazole-Trimethoprim12$67$6

2016: 4 drugs

Part D drugs prescribed in 2016
Ofev19$169,495$8,921
Esbriet13$101,764$7,828
Mycophenolate Mofetil48$4,322$90
Prednisone31$324$10

2015: 1 drug

Part D drugs prescribed in 2015
Prednisone13$290$22

Money from drug and device companies

$5,657 in 2025

Industry payments by year
202515$5,400$5,657
201911None$123

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Boehringer Ingelheim PharmaceuticalsNone$5,657
5 payments
  • Consulting · 2025-04-11 · $5,400
  • Meals · 2025-04-11 · $35
  • Travel · 2025-04-11 · $140
  • Meals · 2025-03-06 · $45
  • Meals · 2025-03-06 · $36
See all 5 published payments
Every published payment
Boehringer Ingelheim PharmaceuticalsConsulting · 2025-04-11None$5,400
Boehringer Ingelheim PharmaceuticalsMeals · 2025-04-11None$35
Boehringer Ingelheim PharmaceuticalsTravel · 2025-04-11None$140
Boehringer Ingelheim PharmaceuticalsMeals · 2025-03-06None$45
Boehringer Ingelheim PharmaceuticalsMeals · 2025-03-06None$36
See earlier years (2019)

2019: $123

Payments by company in 2019
Boehringer Ingelheim PharmaceuticalsOfev$123
1 payment
  • Meals for Ofev · 2019-05-20 · $123

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
Boehringer Ingelheim Pharmaceuticals, Inc. · Extension · 2019Their institution$28,855
Boehringer Ingelheim Pharmaceuticals, Inc. · Extension · 2020Their institution$7,745
United Therapeutics Corporation · Increasing Lung Transplant Availability Using Normothermic Ex Vivo Lung Perfusion (Evlp) at A Dedicated Evlp Facility · 2024This clinician$5,268
Celgene Corporation · A Phase 2, 24-Week, Randomized, Double-Blind, Plac · 2021Their institution$3,425
Celgene Corporation · Ipf-001 Phase 2 (Cc-90001-Ipf-001) (Bms Study Number: Im043-P04) (Cc-90001-Ipf-001) · 2019Their institution$2,884
F. Hoffmann-La Roche AG · Outcomes in Patients With Ipf Treated With Antifibrotic Therapies Compared With Untreated Patients in the U.S. Medicare Population · 2020This clinician$2,756
Boehringer Ingelheim Pharmaceuticals, Inc. · Extension · 2022Their institution$2,740
Celgene Corporation · Ipf-001 Phase 2 (Cc-90001-Ipf-001) (Bms Study Number: Im043-P04) · 2020Their institution$2,136
Boehringer Ingelheim Pharma GmbH & Co.KG · Extension · 2019Their institution$972
Boehringer Ingelheim Pharma GmbH & Co.KG · Extension · 2020Their institution$529

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
76.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1821225541
Licence
CA A113812California A113812: Current · expires 2028-08-31
Trained
University of Minnesota Medical School, 2009
Video visits
Lists video visits
Gender
Male
More record details
Sole proprietor
Yes
Taxonomy
Federal specialty code 207RP1001X (207RP1001X); Internal medicine (207R00000X); Federal specialty code 207RC0200X (207RC0200X)
Mailing address
300 Pasteur Dr, Stanford, CA, 94305
NPI first listed
2009-06-20
NPI last updated
2024-04-15
NPI record certified
2024-04-15

This is when the NPI record was last certified, not a medical board exam.